Clearside Biomedical, Inc. lost $0.47 per diluted share in fiscal year 2024. This represents an increase of 11.3% from the prior fiscal year. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Clearside Biomedical, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Clearside Biomedical, Inc.'s diluted earnings per share in fiscal year 2024?
Clearside Biomedical, Inc. lost $0.47 per diluted share in fiscal year 2024.
How fast is Clearside Biomedical, Inc.'s diluted earnings per share growing?
Clearside Biomedical, Inc. (CLSD) diluted earnings per share rose by 11.3% year over year, from -$0.53 to -$0.47 in fiscal year 2024.
What was Clearside Biomedical, Inc.'s diluted earnings per share in the most recent quarter?
Clearside Biomedical, Inc. (CLSD) reported -$1.14 in diluted earnings per share in Q3 2025. This represents an increase of 26.0% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Clearside Biomedical, Inc. (CLSD) reported on that line in every period on record.
